Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan-coated nanoparticles can effectively deliver positively charged drugs through the skin using iontophoresis.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

The developed scaffold effectively treats chronic wounds by promoting healing and preventing infection.

Nanocarrier technology in cosmetics improves ingredient delivery and effectiveness while reducing side effects.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Nanoparticles can effectively deliver spironolactone to hair follicles for treating alopecia and acne.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

A specific gene mutation causes Olmsted syndrome.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

The new delivery system improved hair growth in alopecia treatment.

Minoxidil nanoparticles significantly boost hair growth in mice compared to regular minoxidil.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Deep eutectic solvents are eco-friendly and effective for extracting useful pharmaceutical compounds.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

The P25H5-O microneedles effectively deliver substances through hair follicles and are safe for skin cells.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.